A detailed history of Groupama Asset Managment transactions in Boston Scientific Corp stock. As of the latest transaction made, Groupama Asset Managment holds 952,044 shares of BSX stock, worth $86.1 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
952,044
Previous 863,963 10.19%
Holding current value
$86.1 Million
Previous $66.5 Billion 3.73%
% of portfolio
1.66%
Previous 0.9%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$72.96 - $84.0 $6.43 Million - $7.4 Million
88,081 Added 10.19%
952,044 $64.1 Billion
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $7.25 Million - $8.37 Million
107,729 Added 14.25%
863,963 $66.5 Billion
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $17.6 Million - $21 Million
305,356 Added 67.72%
756,234 $60.2 Billion
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $21.9 Million - $26.1 Million
450,878 New
450,878 $26.1 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.